NCT01394029View on ClinicalTrials.gov

Observation of Patients With Transfusional Hemosiderosis Treatment With Deferasirox

CompletedOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Transfusional Hemosiderosis
Interventions
DRUG

deferasirox

Trial Locations (10)

11195

Novartis Investigative Site, Amman

11566

Novartis Investigative Site, Cairo

33006

Novartis Investigative Site, Oviedo

Unknown

Novartis Investigative Site, Cairo

Novartis Investigative Site, Barcelona

08916

Novartis Investigative Site, Barcelona

B4 6NH

Novartis Investigative Site, West Midlands

N18 1QX

Novartis Investigative Site, London

N19 5NF

Novartis Investigative Site, London

SE5 9RS

Novartis Investigative Site, London

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY